Clinical Trial Update: Phase I Trial: T4 Immunotherapy of Head and Neck Cancer [Phase 1]

View source ↗

Summary

Phase I clinical trial evaluating T4 Immunotherapy for head and neck cancer; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• T4 Immunotherapy

Snippet

Sponsor: King's College London | Conditions: Head and Neck Cancer | Phase 1 | Status: UNKNOWN